Funding for new drug to treat children with spinal muscular atrophy

By Eva Kolimar
Updated September 3 2018 - 2:45pm, first published May 17 2018 - 12:00pm
Life-changing: Belinda Wormleaton's son Thomas, 8, who has spinal muscular astropy type 2, will benefit from a newly-funded drug to help treat the condition. Picture: John Veage
Life-changing: Belinda Wormleaton's son Thomas, 8, who has spinal muscular astropy type 2, will benefit from a newly-funded drug to help treat the condition. Picture: John Veage

Belinda Wormleaton had never heard of spinal muscular atrophy (SMA) before her son Thomas, was diagnosed with the condition.

Get the latest St George news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.